Arxiv Universal PublishingsCOMPARATIVE CHARACTERISTICS OF CLASSICAL AND NEW ORAL ANTICOAGULANTSYusupov ZiyodullaYuldoshevichauthorLutfullin SaidIrekovichauthorRakhmatillaev Rabbonjon Nomozugliauthor  This article presents a comparative analysis of classical and new oral anticoagulants, highlighting their mechanisms of action, pharmacokinetic properties, clinical applications, advantages, and limitations. Classical anticoagulants, such as warfarin, have been widely used for decades but require regular monitoring and dietary restrictions. In contrast, novel oral anticoagulants (NOACs), including rivaroxaban, apixaban, and dabigatran, offer improved safety profiles, predictable pharmacokinetics, and fewer interactions. The article emphasizes the importance of individualized patient care when choosing the appropriate anticoagulant therapy and outlines current clinical guidelines and research findings related to anticoagulation management.2025-06-09Center for Tech and Media ResearchMaqola

For work being deposited by its own author: In self-archiving this collection of files and associated bibliographic metadata, I grant Arxiv Universal Publishings the right to store them and to make them permanently available publicly for free on-line. I declare that this material is my own intellectual property and I understand that Arxiv Universal Publishings does not assume any responsibility if there is any breach of copyright in distributing these files or metadata. (All authors are urged to prominently assert their copyright on the title page of their work.)

For work being deposited by someone other than its author: I hereby declare that the collection of files and associated bibliographic metadata that I am archiving at Arxiv Universal Publishings is in the public domain. If this is not the case, I accept full responsibility for any breach of copyright that distributing these files or metadata may entail.

Clicking on the Deposit Item Now button indicates your agreement to these terms.